Biden Warns: China Could "Eat Our Lunch" When it Comes to Lithium
Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition.
Get the full scoop on this investment opportunity

MRVFF Insider Trading (Nuvo Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $48,166.04
Insider Selling (Last 12 Months): $0.00

Nuvo Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Nuvo Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nuvo Pharmaceuticals Share Price & Price History

Current Price: $1.20
Price Change: Price Decrease of -0.01 (-0.83%)
As of 11/26/2021 11:32 AM ET

This chart shows the closing price history over time for MRVFF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
Look At This Under-The-Radar Lithium Company

Nuvo Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/23/2021Jesse Francis LedgerSenior OfficerBuy2,200$1.46$3,218.60116,986
6/21/2021Jesse Francis LedgerSenior OfficerBuy2,000$1.44$2,871.00112,086
5/28/2021Anthony Edward DobranowskiDirectorBuy6,000$1.45$8,700.0062,181
5/26/2021Anthony Edward DobranowskiDirectorBuy1,181$1.50$1,771.5056,181
5/20/2021Anthony Edward DobranowskiDirectorBuy10,000$1.60$16,015.0055,000
3/22/2021Jesse Francis LedgerSenior OfficerBuy4,700$1.67$7,849.94110,086
12/22/2020Anthony Edward DobranowskiDirectorBuy9,000$0.86$7,740.0019,000
11/20/2020Anthony Edward DobranowskiDirectorSell8,181$0.81$6,626.6110,000
11/18/2020Anthony Edward DobranowskiDirectorSell24,000$0.83$19,920.0018,181
6/15/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.80$2,000.0097,386
6/12/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.79$1,975.0094,886
6/10/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.80$2,000.0089,886
6/4/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.80$2,000.0079,886
5/28/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.82$2,060.0067,386
5/25/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.79$1,975.0059,886
5/22/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.80$2,000.0057,386
5/20/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.80$2,000.0052,386
5/14/2020Jesse Francis LedgerSenior OfficerBuy2,500$0.73$1,825.0044,886
5/14/2020Robert Paul HarrisDirectorBuy10,000$0.70$7,000.0050,000
3/5/2020Anthony Edward DobranowskiDirectorBuy2,915$0.84$2,448.6042,181
See Full Table
Insider Trading at Nuvo Pharmaceuticals?
Sign-up to receive's daily insider buying and selling report for Nuvo Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Nuvo Pharmaceuticals (OTCMKTS:MRVFF)

Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. Nuvo Pharmaceuticals was founded on August 22, 1983 and is headquartered in Mississauga, Canada.
Read More on Nuvo Pharmaceuticals

Today's Range

Now: $1.20
Low: $1.19
High: $1.20

50 Day Range

MA: $8.47
Low: $0.91
High: $37.97

52 Week Range

Now: $1.20
Low: $0.61
High: $1.93


3,100 shs

Average Volume

7,225 shs

Market Capitalization

$13.68 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals' top insider shareholders include:
  1. Jesse Francis Ledger (Senior Officer)
  2. Anthony Edward Dobranowski (Director)
  3. Robert Paul Harris (Director)
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush."
Experts predict that the global lithium market will balloon by 500%. That's wonderful news for investors, because a "sure-thing" like this appears once in a lifetime. And this small-cap company just snagged what could be one of the world's largest lithium deposits.
Discover This Company's MASSIVE Lithium Opportunit